» Articles » PMID: 37394428

Gut Barrier-microbiota Imbalances in Early Life Lead to Higher Sensitivity to Inflammation in a Murine Model of C-section Delivery

Overview
Journal Microbiome
Publisher Biomed Central
Specialties Genetics
Microbiology
Date 2023 Jul 2
PMID 37394428
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Most interactions between the host and its microbiota occur at the gut barrier, and primary colonizers are essential in the gut barrier maturation in the early life. The mother-offspring transmission of microorganisms is the most important factor influencing microbial colonization in mammals, and C-section delivery (CSD) is an important disruptive factor of this transfer. Recently, the deregulation of symbiotic host-microbe interactions in early life has been shown to alter the maturation of the immune system, predisposing the host to gut barrier dysfunction and inflammation. The main goal of this study is to decipher the role of the early-life gut microbiota-barrier alterations and its links with later-life risks of intestinal inflammation in a murine model of CSD.

Results: The higher sensitivity to chemically induced inflammation in CSD mice is related to excessive exposure to a too diverse microbiota too early in life. This early microbial stimulus has short-term consequences on the host homeostasis. It switches the pup's immune response to an inflammatory context and alters the epithelium structure and the mucus-producing cells, disrupting gut homeostasis. This presence of a too diverse microbiota in the very early life involves a disproportionate short-chain fatty acids ratio and an excessive antigen exposure across the vulnerable gut barrier in the first days of life, before the gut closure. Besides, as shown by microbiota transfer experiments, the microbiota is causal in the high sensitivity of CSD mice to chemical-induced colitis and in most of the phenotypical parameters found altered in early life. Finally, supplementation with lactobacilli, the main bacterial group impacted by CSD in mice, reverts the higher sensitivity to inflammation in ex-germ-free mice colonized by CSD pups' microbiota.

Conclusions: Early-life gut microbiota-host crosstalk alterations related to CSD could be the linchpin behind the phenotypic effects that lead to increased susceptibility to an induced inflammation later in life in mice. Video Abstract.

Citing Articles

Modified neuroimmune processes and emotional behaviour in weaned and late adolescent male and female mice born via caesarean section.

Di Miceli M, Rossitto M, Martinat M, Marchaland F, Kharbouche S, Graland M Sci Rep. 2024; 14(1):29807.

PMID: 39616177 PMC: 11608364. DOI: 10.1038/s41598-024-80770-y.


The Impact of Microbiota-Immunity-Hormone Interactions on Autoimmune Diseases and Infection.

Martinelli S, Nannini G, Cianchi F, Coratti F, Amedei A Biomedicines. 2024; 12(3).

PMID: 38540229 PMC: 10967803. DOI: 10.3390/biomedicines12030616.


Inspecting mother-to-infant microbiota transmission: disturbance of strain inheritance by cesarian section.

Yang R, Wang Y, Ying Z, Shi Z, Song Y, Yan J Front Microbiol. 2024; 15:1292377.

PMID: 38486699 PMC: 10937581. DOI: 10.3389/fmicb.2024.1292377.


An Overview of the Influence of Breastfeeding on the Development of Inflammatory Bowel Disease.

Bertin B, Foligne B, Ley D, Lesage J, Beghin L, Morcel J Nutrients. 2023; 15(24).

PMID: 38140362 PMC: 10745409. DOI: 10.3390/nu15245103.


Early-life gut microbiota and neurodevelopment in preterm infants: a narrative review.

Beghetti I, Barone M, Brigidi P, Sansavini A, Corvaglia L, Aceti A Front Nutr. 2023; 10:1241303.

PMID: 37614746 PMC: 10443645. DOI: 10.3389/fnut.2023.1241303.


References
1.
Lopetuso L, Scaldaferri F, Bruno G, Petito V, Franceschi F, Gasbarrini A . The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors. Eur Rev Med Pharmacol Sci. 2015; 19(6):1068-76. View

2.
Perrier C, Corthesy B . Gut permeability and food allergies. Clin Exp Allergy. 2010; 41(1):20-8. DOI: 10.1111/j.1365-2222.2010.03639.x. View

3.
Camilleri M . Editorial: fecal granins in IBS: cause or indicator of intestinal or colonic irritation?. Am J Gastroenterol. 2012; 107(3):448-50. PMC: 3912945. DOI: 10.1038/ajg.2011.465. View

4.
Vaarala O . Gut microbiota and type 1 diabetes. Rev Diabet Stud. 2013; 9(4):251-9. PMC: 3740694. DOI: 10.1900/RDS.2012.9.251. View

5.
Lemme-Dumit J, Song Y, Lwin H, Hernandez-Chavez C, Sundararajan S, Viscardi R . Altered Gut Microbiome and Fecal Immune Phenotype in Early Preterm Infants With Leaky Gut. Front Immunol. 2022; 13:815046. PMC: 8905226. DOI: 10.3389/fimmu.2022.815046. View